您要查找的是不是:
- The modified semisynthetic process development of idarubicin was achieved in eight steps starting from daunorubicin. 以柔红霉素为原料;经八步反应制得盐酸伊达比星;总收率为24.;2%25。
- Methods: Randomizing trial comparing idarubicin and daunorubicin in 78 newly diagnosed AML. 方法:对78例分别应用去甲氧柔红霉素和柔红霉素治疗的初诊AML病人进行随机对照分析。
- Conclusion Idarubicin is the favorable on the compound chemotherapy for the elderly patients with hematologic mal... 结论在条件许可时,老年血液肿瘤患者选用含去甲氧柔红霉素的联合化疗,可能具有疗效好、不良反应小的优势。
- Objective To analyse the effects of idarubicin on hematologic malignancy elderly patients. 目的去甲氧柔红霉素是一种新的蒽环类抗癌药。
- Objective: Comparing the results of idarubicin and daunorubicin in treating AML. 摘要目的:比较去甲氧柔红霉素和柔红霉素治疗急性髓细胞白血病(AML)的疗效。
- Conclusion: As the therapy containing idarubicin gains advantage over that of containing daunorubicin in CR idarubicin can be the first eptional anthracycline in treating the patients of AML. 结论:含去甲氧柔红霉素的诱导方案比用柔红霉素的方案具有更高的CR,可以作为临床治疗AML的首选蒽环类药物。
- THE IDARUBICIN IN COMBINATION WITH Ara C TREATMENT OF REFRACTORY LEUKEMIA 去甲氧柔红霉素联合Ara-C治疗难治性白血病
- Keywords Idarubicin;Daunorubicin;Semisynthetic method;Process development; 伊达比星;柔红霉素;半合成;工艺改进;
- Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia 运用去甲氧基柔红霉素(伊达比星)和阿糖胞苷诱导疗法治疗复发性急性粒细胞白血病的长期存活观察
- DMDR idarubicin
- Idarubicin 去甲氧正定霉素, 去甲氧基柔红霉素
- idarubicin hydrochloride 盐酸伊达比星<抗肿瘤抗生素>
- idarubicin(IMI-30) 去甲柔红霉素(抗肿瘤药)
- Zavedos see idarubicin 伊达比星